Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,020 INR | -0.48% | +2.14% | +25.74% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.74% | 2.2B | |
+38.69% | 728B | |
+33.05% | 603B | |
-5.82% | 360B | |
+18.73% | 332B | |
+1.10% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.43% | 164B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Natco Pharma : Marketing Partner Gets Tentative Nod for Carfilzomib Vials